Cell migration or cytokinesis and proliferation? - Revisiting the "go or grow" hypothesis in cancer cells in vitro

Experimental Cell Research

Volumn 319, Issue 20, 2013, Pages 3094-3103

  Garay, Tamás ^a   Juhász, Éva ^a   Molnár, Eszter ^a   Eisenbauer, Maria ^b   Czirók, András ^c,d   Dekan, Barbara ^e   László, Viktória ^e   Hoda, Mir Alireza ^e   Döme, Balázs ^e,f   Tímár, József ^a,g   Klepetko, Walter ^e   Berger, Walter ^b   Hegedus, Balázs ^e,g  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^g INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Cytokinesis; Lung cancer; Melanoma; Mesothelioma; Migration; Proliferation

Indexed keywords

FOCAL ADHESION KINASE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DENSITY; CELL DIVISION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MALIGNANT MESOTHELIOMA; MELANOMA CELL; MESOTHELIOMA; ONCOGENE SRC; PRIORITY JOURNAL; VIDEO MICROSCOPY;

EID: 84887160871     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.08.018     Document Type: Article

References (42)

1. Bauer A.L., Jackson T.L., Jiang Y., Rohlf T. Receptor cross-talk in angiogenesis: mapping environmental cues to cell phenotype using a stochastic, Boolean signaling network model. J. Theor. Biol. 2010, 264:838-846.
2. Corcoran A., Del Maestro R.F. Testing the "go or grow" hypothesis in human medulloblastoma cell lines in two and three dimensions. Neurosurgery 2003, 53:174-184. (discussion 184-175).
3. Cox B.D., Natarajan M., Stettner M.R., Gladson C.L. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell. Biochem. 2006, 99:35-52.
4. Czirok A., Schlett K., Madarasz E., Vicsek T. Exponential distribution of locomotion activity in cell cultures. Phys. Rev. Lett. 1998, 81:3038-3041.
5. Endresen L., Tveit K.M., Rugstad H.E., Pihl A. Chemosensitivity measurements of human tumour cells by soft agar assays are influenced by the culture conditions. Br. J. Cancer 1985, 51:843-852.
6. Fedotov S., Iomin A. Migration and proliferation dichotomy in tumor-cell invasion. Phys. Rev. Lett. 2007, 98:118101.
7. 2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 1991, 88:2648-2652.
8. Giese A., Loo M.A., Tran N., Haskett D., Coons S.W., Berens M.E. Dichotomy of astrocytoma migration and proliferation. Int. J. Cancer 1996, 67:275-282.
9. Godlewski J., Nowicki M.O., Bronisz A., Nuovo G., Palatini J., De Lay M., Van Brocklyn J., Ostrowski M.C., Chiocca E.A., Lawler S.E. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell 2010, 37:620-632.
10. Habberstad A.H., Gulati S., Torp S.H. Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIalpha in human anaplastic astrocytomas - an immunohistochemical study. Diagn. Pathol. 2011, 6:43.
11. Hatzikirou H., Basanta D., Simon M., Schaller K., Deutsch A. "Go or grow": the key to the emergence of invasion in tumour progression?. Math. Med. Biol. 2012, 29:49-65.
12. Hazan C., Melzer K., Panageas K.S., Li E., Kamino H., Kopf A., Cordon-Cardo C., Osman I., Polsky D. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma. Cancer 2002, 95:634-640.
13. Hegedus B., Czirok A., Fazekas I., Babel T., Madarasz E., Vicsek T. Locomotion and proliferation of glioblastoma cells in vitro: statistical evaluation of videomicroscopic observations. J. Neurosurg. 2000, 92:428-434.
14. Hegedus B., Zach J., Czirok A., Lovey J., Vicsek T. Irradiation and Taxol treatment result in non-monotonous, dose-dependent changes in the motility of glioblastoma cells. J. Neurooncol. 2004, 67:147-157.
15. Horing E., Harter P.N., Seznec J., Schittenhelm J., Buhring H.J., Bhattacharyya S., von Hattingen E., Zachskorn C., Mittelbronn M., Naumann U. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress. Acta Neuropathol. 2012, 124:83-97.
16. Hubbard W.C., Alley M.C., McLemore T.L., Boyd M.R. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. Cancer Res. 1988, 48:4770-4775.
17. Kadota K., Suzuki K., Colovos C., Sima C.S., Rusch V.W., Travis W.D., Adusumilli P.S. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Mod. Pathol. 2012, 25:260-271.
18. Khoshyomn S., Lew S., DeMattia J., Singer E.B., Penar P.L. Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. J. Neurooncol. 1999, 45:111-116.
19. Kim Y., Roh S., Lawler S., Friedman A. miR451 and AMPK mutual antagonism in glioma cell migration and proliferation: a mathematical model. PLoS ONE 2011, 6:e28293.
20. Ladanyi A., Timar J., Bocsi J., Tovari J., Lapis K. Sex-dependent liver metastasis of human melanoma lines in SCID mice. Melanoma Res. 1995, 5:83-86.
21. Ladanyi A., Timar J., Paku S., Molnar G., Lapis K. Selection and characterization of human melanoma lines with different liver-colonizing capacity. Int. J. Cancer 1990, 46:456-461.
22. Lund-Johansen M., Bjerkvig R., Humphrey P.A., Bigner S.H., Bigner D.D., Laerum O.D. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res. 1990, 50:6039-6044.
23. Luporsi E., Andre F., Spyratos F., Martin P.M., Jacquemier J., Penault-Llorca F., Tubiana-Mathieu N., Sigal-Zafrani B., Arnould L., Gompel A., et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res. Treat. 2012, 132:895-915.
24. Maiuri P., Terriac E., Paul-Gilloteaux P., Vignaud T., McNally K., Onuffer J., Thorn K., Nguyen P.A., Georgoulia N., Soong D., et al. The first World Cell Race. Curr. Biol.: CB 2012, 22:R673-R675.
25. Martin B., Paesmans M., Mascaux C., Berghmans T., Lothaire P., Meert A.P., Lafitte J.J., Sculier J.P. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br. J. Cancer 2004, 91:2018-2025.
26. Merzak A., McCrea S., Koocheckpour S., Pilkington G.J. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br. J. Cancer 1994, 70:199-203.
27. Milde-Langosch K., Karn T., Muller V., Witzel I., Rody A., Schmidt M., Wirtz R.M. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer. Breast Cancer Res. Treat. 2013, 137:57-67.
28. Mueller B.M., Romerdahl C.A., Trent J.M., Reisfeld R.A. Suppression of spontaneous melanoma metastasis in SCID mice with an antibody to the epidermal growth factor receptor. Cancer Res. 1991, 51:2193-2198.
29. Ohsie S.J., Sarantopoulos G.P., Cochran A.J., Binder S.W. Immunohistochemical characteristics of melanoma. J. Cutaneous Pathol. 2008, 35:433-444.
30. Paluch E., Piel M., Prost J., Bornens M., Sykes C. Cortical actomyosin breakage triggers shape oscillations in cells and cell fragments. Biophys. J. 2005, 89:724-733.
31. Penar P.L., Khoshyomn S., Bhushan A., Tritton T.R. Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain. Neurosurgery 1997, 40:141-151.
32. Preusser M., Heinzl H., Gelpi E., Hoftberger R., Fischer I., Pipp I., Milenkovic I., Wohrer A., Popovici F., Wolfsberger S., et al. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology 2008, 53:39-47.
33. Roth W., Wild-Bode C., Platten M., Grimmel C., Melkonyan H.S., Dichgans J., Weller M. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 2000, 19:4210-4220.
34. Schaller M.D. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J. Cell Sci. 2010, 123:1007-1013.
35. Schultz C., Lemke N., Ge S., Golembieski W.A., Rempel S.A. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res. 2002, 62:6270-6277.
36. Stewart M.P., Helenius J., Toyoda Y., Ramanathan S.P., Muller D.J., Hyman A.A. Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding. Nature 2011, 469:226-230.
37. Tamaki M., McDonald W., Amberger V.R., Moore E., Del Maestro R.F. Implantation of C6 astrocytoma spheroid into collagen type I gels: invasive, proliferative, and enzymatic characterizations. J. Neurosurg. 1997, 87:602-609.
38. Tan X., Wang S., Yang B., Zhu L., Yin B., Chao T., Zhao J., Yuan J., Qiang B., Peng X. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PLoS ONE 2012, 7:e49570.
39. Torp S.H. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin. Neuropathol. 2002, 21:252-257.
40. Vereecken P., Laporte M., Heenen M. Significance of cell kinetic parameters in the prognosis of malignant melanoma: a review. J. Cutaneous Pathol. 2007, 34:139-145.
41. Wang S.E., Hinow P., Bryce N., Weaver A.M., Estrada L., Arteaga C.L., Webb G.F. A mathematical model quantifies proliferation and motility effects of TGF on cancer cells. Comput. Math. Methods M 2009, 10:71-83.
42. Zhang W., Law R.E., Hinton D.R., Couldwell W.T. Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett. 1997, 120:31-38.